1. Home
  2. CNK vs GRFS Comparison

CNK vs GRFS Comparison

Compare CNK & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cinemark Holdings Inc Cinemark Holdings Inc.

CNK

Cinemark Holdings Inc Cinemark Holdings Inc.

HOLD

Current Price

$37.04

Market Cap

4.3B

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

N/A

Current Price

$8.05

Market Cap

5.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CNK
GRFS
Founded
1984
1940
Country
United States
Spain
Employees
N/A
N/A
Industry
Movies/Entertainment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
5.2B
IPO Year
2007
2008

Fundamental Metrics

Financial Performance
Metric
CNK
GRFS
Price
$37.04
$8.05
Analyst Decision
Buy
Hold
Analyst Count
10
2
Target Price
$33.70
$10.15
AVG Volume (30 Days)
2.5M
529.1K
Earning Date
05-01-2026
07-28-2022
Dividend Yield
1.24%
1.80%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,115,000,000.00
N/A
Revenue This Year
$11.01
$4.49
Revenue Next Year
$3.70
$6.42
P/E Ratio
N/A
$18.67
Revenue Growth
2.15
N/A
52 Week Low
$21.60
$6.96
52 Week High
$38.98
$10.23

Technical Indicators

Market Signals
Indicator
CNK
GRFS
Relative Strength Index (RSI) 61.01 56.17
Support Level $36.28 $7.87
Resistance Level $38.98 $8.36
Average True Range (ATR) 0.97 0.18
MACD -0.24 -0.00
Stochastic Oscillator 36.10 54.29

Price Performance

Historical Comparison
CNK
GRFS

About CNK Cinemark Holdings Inc Cinemark Holdings Inc.

Cinemark Holdings Inc is a geographically diverse operator in the motion picture exhibition industry in the United States. The company generates revenue from filmed entertainment box office receipts and concession sales, with additional revenue from screen advertising, screen rentals, and other revenue streams, such as transactional fees, vendor marketing promotions, studio trailer placements, meeting rentals, and electronic video games located in some of the theatres. Cinemark manages its business under two reportable segments: U.S. markets and international markets. The majority of its revenue is generated from the U.S. markets segment.

About GRFS Grifols S.A.

Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.

Share on Social Networks: